Janku Filip 4

What Happened Janku Filip, Chief Medical Officer of Monte Rosa Therapeutics (GLUE), reported a sale of 9,189 common shares on 2026-02-23 at $19.50 per share, producing gross proceeds of approximately $179,161. The transaction is reported on a Form 4 as a sale (code S), described as an open-market or private sale.

Key Details

• Transaction date: 2026-02-23; Filing date: 2026-02-24 (next-day filing; no late filing indicated).
• Price and amount: 9,189 shares sold at $19.50 each; gross proceeds ≈ $179,161.
• Transaction type: Sale reported on Form 4 (S); described as open-market or private sale.
• Shares owned after transaction: Not reported in the provided filing summary.
• Footnotes/plan disclosures: No 10b5-1 plan, tax withholding, or other footnotes were provided in the supplied details.

Context Sales by company officers can be routine (liquidity, diversification, tax planning) and do not by themselves indicate a change in company outlook. This report documents a straightforward disposal of shares; absent additional disclosures (e.g., 10b5-1 plan or related notes), no specific motive is stated.